Company Filing History:

9 out of 17

Sharps Associates

patents

Arthur D. Little, Inc.

patents

Years Active: 1976-1978

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4126695 - Anti-glaucoma composition and method (1978-11-21),

2. 4126694 - Composition and method for treating glaucoma (1978-11-21),

3. 4042694 - Novel heterocyclic esters of benzopyranopyridines (1977-08-16),

4. 4020163 - Use of heterocyclic esters of 5H-[1]benzopyrano [3,4-b]pyridines as (1977-04-26),

5. 3994922 - Benzopyrans and intermediates for the preparation of pyrrolo benzopyrans (1976-11-30),

6. 3991194 - Heterocyclic esters of benzopyranopyridines (1976-11-09),

7. 3987190 - Method of treating hypertension with, and compositions useful therein (1976-10-19),

8. 3972880 - Morpholine containing esters of thienobenzopyrans and (1976-08-03),

9. 3960871 - Esters of thienobenzopyrans and thiopyranobenzopyrans (1976-06-01),

10. 3951970 - Resorcinol amine derivatives (1976-04-20),

11. 3941782 - Heterocyclic esters of benzopyrans (1976-03-02),

12. 3940421 - Intermediates for the preparation of thienobenzopyrans and (1976-02-24),

13. 3934024 - Method of producing analgesia and compositions useful therein (1976-01-20),

Title: The Innovations of Harry George Pars

Introduction

Harry George Pars is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 13 patents to his name, Pars has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Among his latest patents are compositions and methods for treating glaucoma. One of his notable inventions involves tetrahydrodibenzopyrans, which are effective anti-glaucoma agents. These compounds are characterized by their structure, where R, R1, and R2 are alkyl groups containing 1 to 4 carbon atoms, and they are free from significant central nervous system activity when applied topically. Another patent focuses on a similar composition, where R1 can be hydrogen or acetyl, and R2 is an alkyl group, again demonstrating effectiveness as an anti-glaucoma agent.

Career Highlights

Throughout his career, Harry George Pars has worked with several companies, including Sharps Associates and Sisa Incorporated. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to the development of innovative treatments.

Collaborations

Some of his notable coworkers include Raj Kumar Razdan and Louis Selig Harris. Their collaboration has likely played a role in the successful development of Pars's inventions.

Conclusion

Harry George Pars is a distinguished inventor whose work has significantly impacted the treatment of glaucoma. His innovative patents and collaborations reflect his dedication to improving medical outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com